Gastric Emptying After Bread Consumption
The Effect of Dietary Fiber-enriched Bread on Gastric Emptying and Postprandial Glucose Levels
1 other identifier
interventional
22
1 country
1
Brief Summary
The rate of gastric emptying is proposed to be one of the major determinants of postprandial glycemia. A slower gastric emptying will thus result in a less pronounced rise in blood glucose, which is especially desirable in diabetes care as it will highly influence the overall glycemic control. The present study aims to investigate the rate of gastric emptying and postprandial blood glucose levels in response to the intake of bread with different dietary fiber-content. Though bread is one of the major sources of dietary carbohydrates in Central- and Northern Europe, the mechanism and the metabolic effects of bread consumption, however, is investigated in a limited number of studies.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2020
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 21, 2020
CompletedFirst Posted
Study publicly available on registry
October 1, 2020
CompletedStudy Start
First participant enrolled
October 20, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 15, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
February 15, 2021
CompletedJuly 13, 2021
July 1, 2021
3 months
September 21, 2020
July 7, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Difference in gastric emptying (antral area, cm2) )
Differences in antral area (cm2) at different time points after ingestion of standardised meals. The antral area is measured by real-time ultrasonography.
2 hours
Secondary Outcomes (4)
Satiety hormones
2 hours
Subjective satiety
2 hours
Postprandial blood glucose
2 hours
Insulin
2 hours
Study Arms (2)
Beta-glucan bread
EXPERIMENTALParticipants will receive a standardised meal consisting of beta-glucan-enriched bread (in an amount corresponding to 25 g of available dietary carbohydrates) and water (250 ml). The bread is produced by NOFIMA AS, one of the collaborating parties. The participants will be asked to spend approximately 10 minutes consuming the standardised meal.
Control bread
SHAM COMPARATORParticipants will receive a standardised meal consisting of a wheat bread with no additives (in an amount corresponding to 25 g of available dietary carbohydrates) and water (250 ml). The bread is produced by NOFIMA AS, one of the collaborating parties. The participant will be asked to spend approximately 10 minutes consuming the standardised meal.
Interventions
Beta-glucan is a dietary fiber with beneficial health effects, both on cholesterol levels and potentially blood glucose levels.
Eligibility Criteria
You may qualify if:
- Adults 18-40 years
- BMI: 18.5-30 kg/m2
- Healthy
You may not qualify if:
- Celiac disease, non-celiac gluten sensitivity or wheat allergy and intolerance
- Use of medication that can affect gastric emptying
- Gastroparesis
- Gastrointestinal diseases
- Gastrointestinal surgery including bariatric surgery
- Chronic alcohol abuse
- Current smoker
- Pregnant or lactating women
- Diabetes mellitus type 1 and 2
- Anorexia nervosa or bulimia nervosa
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Bergenlead
- The Research Council of Norwaycollaborator
Study Sites (1)
University of Bergen
Bergen, 5021, Norway
Related Publications (1)
Revheim I, Ballance S, Standal AF, Rieder A, Dierkes J, Buyken AE, Gilja OH, Hausken T, Rosendahl-Riise H. The acute effect of a beta-glucan-enriched oat bread on gastric emptying, GLP-1 response, and postprandial glycaemia and insulinemia: a randomised crossover trial in healthy adults. Nutr Metab (Lond). 2024 Mar 18;21(1):13. doi: 10.1186/s12986-024-00789-w.
PMID: 38500209DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Jutta Dierkes, PhD
University of Bergen
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
September 21, 2020
First Posted
October 1, 2020
Study Start
October 20, 2020
Primary Completion
January 15, 2021
Study Completion
February 15, 2021
Last Updated
July 13, 2021
Record last verified: 2021-07
Data Sharing
- IPD Sharing
- Will not share
There is not a plan to make IPD available